Eyes on New Product Development: Regulations, Generics, and Disruptive Technologies

被引：0
作者：
Novack, Gary D. [1 ,2 ]
机构：
[1] PharmaLog Dev Inc, 17 Bridgegate Dr, San Rafael, CA 94903 USA
[2] Univ Calif Davis, Sch Med, Dept Ophthalmol, Sacramento, CA 95817 USA
来源：
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | 2021年 / 37卷 / 03期
关键词：
D O I：
10.1089/jop.2021.29075.gdn
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：139 / 140
页数：2
相关论文
共 5 条
  • [1] [Anonymous], 2020, FED REGISTER, V85, P75331
  • [2] Herman A., 2021, WALL ST J
  • [3] Adverse effects of topical timolol: Safety concerns and implications for dermatologic use
    Jaeho, Daniel
    Kaur, Ramanjot
    Gallegos, Anthony
    West, Kaitlyn
    Yang, Hsinya
    Schaefer, Saul
    Tchanque-Fossuo, Catherine
    Dahle, Sara E.
    Isseroff, R. Rivkah
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (01) : 199 - 200
  • [4] Bridging the Gap at Warp Speed - Delivering Options for Preventing and Treating Covid-19
    Slaoui, Moncef
    Greene, Shannon E.
    Woodcock, Janet
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20) : 1809 - 1901
  • [5] Drug Regulation in the Era of Individualized Therapies
    Woodcock, Janet
    Marks, Peter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17) : 1678 - 1680
1